Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

D.C. Circuit Strikes Down TCPA Fax Opt-Out Requirement

Firm Publication

Publications

March 31, 2017

The D.C. Circuit today overturned the Federal Communications Commission's requirement that fax advertisements always include opt-out notices. In Yaakov v. FCC, the court held that the FCC lacks authority under the Telephone Consumer Protection Act (TCPA) to regulate communications sent with the recipient's prior express invitation or permission. The TCPA expressly authorizes the FCC to issue rules regulating unsolicited fax advertisements—and requires that those faxes contain an opt-out notice—but makes no mention of solicited faxes. The D.C. Circuit thus held that the FCC's regulation exceeded the scope of the agency's authority to regulate solicited fax communications.

This decision eases the regulatory burden associated with faxes and has a significant impact on health care companies' and other industries' fax communications, where providers and manufacturers rely on faxes to comply with regulatory obligations. The Consumer Financial Services Group at Bass, Berry & Sims previously published an alert on oral argument in Yaakov v. FCC, which provides more information on the issues in this case.


In Case You Missed It:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.